Argenx, Genmab pool expertise on antibody discovery, joining forces to expand into new therapeutic areas

Two powerhouses of the European biopharma sector are joining forces. Under a multiyear, cost-sharing alliance, argenx and Genmab are opening their suites of antibody technologies to each other to jointly go after cancer and immunology targets.